InvestorsHub Logo
Followers 35
Posts 2834
Boards Moderated 0
Alias Born 03/20/2011

Re: CHM_760 post# 12290

Thursday, 07/24/2014 11:54:21 AM

Thursday, July 24, 2014 11:54:21 AM

Post# of 40492
Upgrade

11:15 EDT INO Inovio upgraded to Buy from Hold at Aegis
Aegis upgraded Inovio to Buy following positive top-line data from the clinical trial of its lead human papillomavirus DNA-based vaccine, VGX-3100, in patients with high-grade cervical dysplasia. Price target raised to $19 from $10.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News